CSIMarket
 
Resmed Inc   (RMD)
 

on the higher pace

company reported third quarter of 2023 operating surplus of $300.671 million


Published 2023-04-28T12:21:42+00:00
Goran Soko / CSIMarket.com Contributer


Medical_ultrasound_examination_pd company declared earnings per share growth of 29.51 % to $1.58 on diminishing Revenue of -9.638 % to $1.11 billion in the Mar 31 2023 report, year on year.

In the preceding quarter RMD realized Revenue of $1.03 billion and bottom line of $1.53 per share.


Net profits of $232.500 million in the third quarter of 2023 earnings season increased by 29.88 % from net earnings of $179.012 million reported in the third quarter of 2023 earnings season a year ago. Resmed Inc also emphasized it's improving profit margins, where net margin rose to 20.97% in third quarter of 2023 earnings season, and operating margin edged up to 27.12%.
Operating earnings, on the other hand, improved just 28.35% to $300.671 million.

Resmed Inc is expected to report next financial recent numbers on August 10, 2023.



Resmed Inc's Receivables Turnover Ratio

Resmed Inc's Free Cash Flow Margin





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071